Veeva Systems Cl A had its Relative Strength (RS) Rating upgraded from 66 to 71 Friday — a welcome improvement, but still below the 80 or higher score you prefer to see.
When To Sell Stocks To Lock In Profits And Minimize Losses
This exclusive rating from Investor's Business Daily identifies share price performance with a 1 (worst) to 99 (best) score. The score shows how a stock's price performance over the last 52 weeks stacks up against all the other stocks in our database.
History reveals that the stocks that go on to make the biggest gains typically have an RS Rating north of 80 in the early stages of their moves. See if Veeva Systems Cl A can continue to show renewed price strength and clear that threshold.
Veeva Systems Cl A is building a flat base with a 296.72 buy point. See if it can break out in heavy trade.
Veeva Systems Cl A showed 23% EPS growth in the latest quarterly report. Sales gains came in at 17%.
Veeva Systems Cl A earns the No. 3 rank among its peers in the Computer Software-Medical industry group. OptimizeRx is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
